Leonteq Securities »

Intellia Therapeutics shares owned by Leonteq Securities

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Leonteq Securities from 13F filings

Historical chart of Leonteq Securities investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Leonteq Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Leonteq Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $511k 57k 8.99
2025-03-31 $66k 9.4k 7.10
2024-12-31 $1.1k 91 11.66
2024-09-30 $1.6k 79 20.54
2024-06-30 $5.2k 234 22.38

More positions owned by Leonteq Securities

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Meta Platforms Cl A Put Option (META)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Stellantis SHS (STLA)
Micron Technology (MU)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Put Option (MSFT)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Citigroup Com New Put Option (C)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)

View all positions for Leonteq Securities

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
State Street Corporation
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
D. E. Shaw & Co
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Two Sigma Advisers
Dimensional Fund Advisors
Susquehanna International
FMR

View all funds holding Intellia Therapeutics